CRISPR technology has rapidly advanced in recent years, with new tools and clinical breakthroughs. Highlight the recent developments in CRISPR-based gene editing technology applications. Discuss the opportunities and ethical challenges these advancements present for healthcare and society.
Aakash Om Trivedi, AIR 73, 2025
CRISPR technology used Cas-9 as gene-scissor for gene-editing and modification as part of biotechnology.
Recent development in CRISPR-Cas9
1. More better identification and removal reduce risk to mutation 2. Small sequence modification possible now, earlier only big e.g) ICMR CRISPR @ 2025 3. Targeted modification in mRNA also possible e.g) m-RNA vaccine 4. Non-palindromic modification x seach
Opportunities of CRISPR
1. gene - disease counter e.g. haemophilia 2. low - cost compare to earlier TALEN 3. faster vaccine development e.g. COVID moderna 4. Precise, so less scope of mutation 5. Children: disability reduction e.g. Germline modification 6. Agriculture: lead to better variant e.g. more yield, pest resistant 7. Country specific: gene research supported through CRISPR.
Ethical Challenges
1. Eugenics Designer baby -> playing with evolution 2. Germline modification seen against religious ethics. eg) Christian ethics 3. Gene - Divide : as poor can't afford it. 4. Promote un-wanted mutation if rampant use.
Way - Ahead
1. No germline modification (ICMR guideline) 2. low cost through subsidies 3. more R&D spend & for research eg) only 0.7 ! 4. Center of excellence for use in Agriculture eg) B2RAC collaboration 5. Proper procedures for CRISPR
Thus, V. M Kamakoti Committee recommendation on Biotechnology development implement.